Neulasta (pegfilgrastim)

DRUG2 trials

Sponsors

Amgen, M.D. Anderson Cancer Center

Conditions

Breast CancerLung CancerNeutropeniaNon-Hodgkin's LymphomaOvarian CancerSarcoma

Phase 4

A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer

CompletedNCT00277160

AmgenBreast Cancer, Lung Cancer, Neutropenia +2

Start: 2002-06-30End: 2005-01-31Updated: 2010-10-08

Unknown Phase

Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide

CompletedNCT00283621

M.D. Anderson Cancer CenterSarcoma

Start: 2003-06-02End: 2006-04-12Updated: 2018-11-07